<?xml version="1.0" encoding="UTF-8"?>
<p id="p0130">The US-FDA approved antihelmintic drug Niclosamide is also explored as an anticancer, antibacterial and antiviral agent. Also, it was found to be effective as a protease inhibitor in shedding the SARS-CoV and MERS-CoV replication and viral antigen synthesis was suppressed by Niclosamide at 1.56 μM [
 <xref rid="bb0495" ref-type="bibr">99</xref>,
 <xref rid="bb0500" ref-type="bibr">100</xref>]. It might be a good pharmacological agent to treat SARS-CoV-2 infections as well and studies may be designed to evaluate the same in vitro and clinical conditions [
 <xref rid="bb0505" ref-type="bibr">101</xref>]. The FDA approved antiparasitic drug Ivermectin is widely used as an essential medicine to treat lymphatic filariasis, strongiloidiasis, ascariasis, head lice, scabies, and river blindness etc. [
 <xref rid="bb0510" ref-type="bibr">102</xref>]. Ivermectin was tested for its repurposing antiviral activity against SARS-CoV-2, where it has shown excellent antiviral activity. The in vitro results suggest that Ivermectin reduced viral RNA load &gt;5000 fold with 5 μM concentration at 48 h [
 <xref rid="bb0515" ref-type="bibr">103</xref>]. It might be a good repurposing drug in treating SARS-CoV-2 infections and further studies are required for this specific use.
</p>
